There is a great need for strategies to generate well-validated, protein-specific affinity reagents to explore the human proteome and to subsequently develop diagnostic and therapeutic antibodies 1.

A recent study conducted at the University of Texas at Austin, USA, has identified a highly conserved neutralizing antibody binding site on the spike S2 domain of severe acute respiratory syndrome ...

In a recent study posted to the bioRxiv* preprint server, researchers designed an efficient vaccine design against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infections. Study: ...

“Patent strategies for antibody medicines should include obtaining an antibody sequence-based patent covering the developed drug, in addition to an epitope-based patent.” Patents involving antibody ...

Epitope information is increasingly being used to understand the mechanism of action (MoA) of therapeutic monoclonal antibodies (mAbs), as well as to overcome the mounting challenges of patenting them ...

PURPOSE: To study distribution and toxicity of cytolytic T lymphocytes (CTLs) against a single melanoma epitope. CONCLUSION: CTLs immunized against a single melanoma epitope were nontoxic but did not ...

Current flu vaccines provide only limited coverage against seasonal strains of influenza viruses. The identification of V H 1-69 antibodies that broadly neutralize almost all influenza A group 1 ...

AUSTIN, Texas, May 12, 2025--(BUSINESS WIRE)--ImmunoPrecise Antibodies Ltd. (IPA) (NASDAQ:IPA) a leader in AI-driven biotherapeutics, is pleased to announce today new benchmarking results that ...

There are numerous aspects to consider when choosing the right assay for your antibody-selection experiments. There are three common epitope-binning assays to choose from: in-tandem assay, classical ...